AR073699A1 - 2-[1h-bencimidazol-2(3h)-iliden]-2-(pirimidin-2-il) acetamidas y 2-[benzotiazol-2(3h)-iliden]-2-(pirimidin-2-il) acetamidas inhibidores de quinasas, composiciones farmaceuticas que las contienen y su uso en el tratamiento del cancer. - Google Patents

2-[1h-bencimidazol-2(3h)-iliden]-2-(pirimidin-2-il) acetamidas y 2-[benzotiazol-2(3h)-iliden]-2-(pirimidin-2-il) acetamidas inhibidores de quinasas, composiciones farmaceuticas que las contienen y su uso en el tratamiento del cancer.

Info

Publication number
AR073699A1
AR073699A1 ARP090103727A ARP090103727A AR073699A1 AR 073699 A1 AR073699 A1 AR 073699A1 AR P090103727 A ARP090103727 A AR P090103727A AR P090103727 A ARP090103727 A AR P090103727A AR 073699 A1 AR073699 A1 AR 073699A1
Authority
AR
Argentina
Prior art keywords
substituted
acetamids
iliden
pirimidin
alkyl
Prior art date
Application number
ARP090103727A
Other languages
English (en)
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Publication of AR073699A1 publication Critical patent/AR073699A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Reivindicacion 1: Un compuesto de la formula, (1) o su sal, donde X es NH o S; m es 0, 1 , 2 o 3; n es 0, 1, 2, 3 o 4; R1 es alquilo, alquilo sustituido, heteroalquilo, heteroalquilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, aralquilo, aralquilo sustituido, heteroaralquilo, heteroaralquilo sustituido, halo, nitro o ciano o es -OR, -SR, -C(O)R, .-OC(O)R, -C(O)OR, -NR2, -SO2OR, -OSO2R, -SO2NR2, -NR3SO2R, -CONR2, -NR3COR y -NR3C(O)OR, donde cada R es, de modo independiente, hidrogeno, alquilo, alquilo sustituido, heteroalquilo, heteroalquilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, aralquilo, aralquilo sustituido, heteroaralquilo o heteroaralquilo sustituido y R3 es hidrogeno o alquilo C1-3; y R2 es alquilo, alquilo sustituido, heteroalquilo, heteroalquilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, aralquilo, aralquilo sustituido, heteroaralquilo, heteroaralquilo sustituido, halo, nitro o ciano o es -OR, -SR, -C(O)R, .-OC(O)R, -C(O)OR, -NR2, -SO2OR, -OSO2R, -SO2NR2, -NR3SO2R, -CONR2, -NR3COR y -NR3C(O)OR, donde cada R es, de modo independiente, hidrogeno, alquilo, alquilo sustituido, heteroalquilo, heteroalquilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, aralquilo, aralquilo sustituido, heteroaralquilo o heteroaralquilo sustituido y R3 es hidrogeno o alquilo C1-3.
ARP090103727A 2008-09-29 2009-09-28 2-[1h-bencimidazol-2(3h)-iliden]-2-(pirimidin-2-il) acetamidas y 2-[benzotiazol-2(3h)-iliden]-2-(pirimidin-2-il) acetamidas inhibidores de quinasas, composiciones farmaceuticas que las contienen y su uso en el tratamiento del cancer. AR073699A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10086908P 2008-09-29 2008-09-29

Publications (1)

Publication Number Publication Date
AR073699A1 true AR073699A1 (es) 2010-11-24

Family

ID=41268298

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090103727A AR073699A1 (es) 2008-09-29 2009-09-28 2-[1h-bencimidazol-2(3h)-iliden]-2-(pirimidin-2-il) acetamidas y 2-[benzotiazol-2(3h)-iliden]-2-(pirimidin-2-il) acetamidas inhibidores de quinasas, composiciones farmaceuticas que las contienen y su uso en el tratamiento del cancer.

Country Status (16)

Country Link
US (1) US8129396B2 (es)
EP (1) EP2346856A1 (es)
JP (1) JP5555239B2 (es)
KR (1) KR20110059740A (es)
CN (1) CN102159568A (es)
AR (1) AR073699A1 (es)
AU (1) AU2009296482A1 (es)
BR (1) BRPI0918509A2 (es)
CA (1) CA2734472A1 (es)
CL (1) CL2011000686A1 (es)
IL (1) IL211036A0 (es)
MX (1) MX2011002986A (es)
RU (1) RU2011113230A (es)
TW (1) TW201012811A (es)
WO (1) WO2010036873A1 (es)
ZA (1) ZA201101665B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103502313B (zh) 2012-05-03 2015-07-08 株式会社Lg化学 聚酰胺酸、光敏树脂组合物、干燥膜以及电路板

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1110957A1 (en) * 1999-12-24 2001-06-27 Applied Research Systems ARS Holding N.V. Benzazole derivatives and their use as JNK modulators
US20080193448A1 (en) * 2005-05-12 2008-08-14 Pfizer Inc. Combinations and Methods of Using an Indolinone Compound
CN101163473A (zh) * 2005-05-12 2008-04-16 辉瑞大药厂 使用舒尼替尼苹果酸盐的抗癌组合疗法
EP1746096A1 (en) 2005-07-15 2007-01-24 4Sc Ag 2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer

Also Published As

Publication number Publication date
IL211036A0 (en) 2011-04-28
US8129396B2 (en) 2012-03-06
RU2011113230A (ru) 2012-11-10
ZA201101665B (en) 2011-10-26
WO2010036873A1 (en) 2010-04-01
CN102159568A (zh) 2011-08-17
TW201012811A (en) 2010-04-01
AU2009296482A1 (en) 2010-04-01
BRPI0918509A2 (pt) 2015-12-01
CA2734472A1 (en) 2010-04-01
CL2011000686A1 (es) 2012-02-24
KR20110059740A (ko) 2011-06-03
JP2012504130A (ja) 2012-02-16
EP2346856A1 (en) 2011-07-27
MX2011002986A (es) 2011-04-21
JP5555239B2 (ja) 2014-07-23
US20100081653A1 (en) 2010-04-01

Similar Documents

Publication Publication Date Title
CL2004000917A1 (es) Compuestos derivados de tiazol; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades mediadas por 3-cinasa de dosfatidilnositol tal como enfermedades respiratorias, alergias, artritis reumatoide, osteoa
UY29360A1 (es) Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones.
BR112014005226A2 (pt) derivados de benzonitrila como inibidores de cinase
BRPI0409198A (pt) derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
SV2009002865A (es) Uso de oxazolidinonas para el tratamiento y profilaxis de microangiopatias
ECSP109903A (es) Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares
DK2203430T3 (da) N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
CY1107846T1 (el) Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
CY1117792T1 (el) Ανταγωνιστες toy trpv4
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
ES2531159T3 (es) Compuestos y métodos para el tratamiento del cáncer
AR081819A1 (es) Derivados de pirimidil-piperidinil-oxipiridinona, composiciones farmaceuticas que los contienen y uso de los mismos para tratar diabetes, dislipemias, obesidad y otras enfermedades
DE602007001463D1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
ATE438617T1 (de) Substituierte cyclohexyl-1,4-diamin-derivate
MX2019000103A (es) Profarmacos de fosforo de estimuladores de guanilato ciclasa soluble (sgc).
CY1115729T1 (el) Τρικυκλικη ενωση και φαρμακευτικη χρηση αυτης
TW200639155A (en) Thiazolidinones, their production and use as pharmaceutical agents
EA201692065A1 (ru) Применение 1,3,5-триазин-2-ил фосфорамидатного соединения в синтезе софосбувира
UY30545A1 (es) Derivados sustituidos del acido acilamino-benzoico, composiciones que los contienen y aplicaciones
MX2010005787A (es) Derivados de imizado-tiazole en la forma de inhibidores de cinasa de proteina.
SE0403086D0 (sv) Compounds
BRPI0518998A2 (pt) âmega-feniloctanamidas

Legal Events

Date Code Title Description
FB Suspension of granting procedure